Omega-3 Fatty Acids Show Promise in Fighting Deadly CancersSeptember 2006
Omega-3s Shield Skin Against UV Light-Induced Cancer
Exposure to ultraviolet (UV) light contributes to several kinds of skin cancer. For more than a decade, scientists have known that omega-3 fats help reduce the skin’s sensitivity to UV rays.37
Researchers recently discovered that omega-3s can help reduce the inflammatory skin response commonly known as sunburn, in part by lowering levels of an inflammatory prostaglandin. After adults supplemented with EPA for three months, they required much higher doses of UV radiation to redden their skin and did not experience the increased inflammation that usually follows sun exposure.38
A later study indicates that omega-3 fatty acids may reduce risk for skin cancer. In adults who supplemented with EPA daily for three months, omega-3 supplementation decreased the skin’s susceptibility to sunburn and reduced by 50% the expression of a gene associated with UV light-induced skin cancer. In addition, the supplemented individuals had significantly fewer UV light-induced breaks in DNA strands.
EPA supplementation may thus help protect against UV-induced DNA damage that can lead to cancer, and long-term supplementation may help to reduce the risk of skin cancer in humans.39
Omega-3s Enhance Effects of Cancer-Fighting Drugs
In the search for effective cancer-fighting regimens, scientists have explored the efficacy of combining omega-3 fatty acids with conventional pharmaceutical drugs. Exciting evidence suggests that omega-3s actually help to sensitize cancer cells to the effects of standard chemotherapy drugs. For example, researchers found that cancer cells with a higher concentration of DHA in their membranes were more susceptible to cell death from administration of the chemotherapy drug doxorubicin.40
Similar synergistic results were found when DHA was added to chemotherapy drugs in the taxane family, such as Taxol® and Taxotere®. Dramatic increases in tumor cell death occurred not only when DHA and the drug were administered together, but also when DHA was given before the drug. This suggests that DHA administration might help prepare patients for chemotherapy with taxane drugs, enhancing the drugs’ efficacy in fighting cancer.41
Omega-3s Promote Healing From Cancer Surgery
Emerging research suggests that omega-3 fatty acids may help fight inflammation and prevent infection in individuals undergoing surgical treatment for cancer. Surgical treatment of any kind provokes a powerful, immediate inflammatory response, often coupled with immune suppression, which can lead to infections. Such inflammatory and immune challenges can drain the body’s resources for recovery.5 Omega-3 fatty acids may help support healing from cancer surgery.
Researchers have noted that omega-3 fatty acids reduce levels of inflammation while boosting beneficial immune responses, providing a “one-two punch” to suppress damaging post-operative inflammation and reduce the risk of post-operative infections.5
Omega-3 fatty acids may also be critically important for cancer patients who must undergo surgery.42 Omega-3 supplementation has been associated with fewer complications of surgery, as well as with shorter hospital stays.43,44 Because of the modest blood-thinning effects of omega-3 fatty acids, patients should consult with their surgeons before beginning supplementation.45
In one study, omega-3 fatty acids provided important benefits for patients who underwent surgery for intestinal cancers. Those who supplemented with omega-3 fatty acids before and after surgery experienced fewer complications and infections compared to patients who did not supplement. Additionally, the total costs of surgical treatment were substantially lower in the omega-3-supplemented group. Omega-3 fatty acids may thus help individuals to better tolerate surgical treatment of cancer.46
A similar study showed that patients who received omega-3 supplements before surgery for colorectal cancer demonstrated better immune responses and dramatically lower incidences of infection. Omega-3s thus helped promote rapid healing from surgery in cancer patients. This study may have broad implications for many types of patients undergoing surgery.47
Of the many health benefits conferred by omega-3 fatty acids, their ability to prevent the development of cancer by quelling dangerous inflammation and promoting healthy gene expression may be among the most significant.
These essential fats likewise hold equal promise for those who are already battling cancer, as new findings suggest that omega-3s may exert cancer-fighting effects alone or in combination with pharmaceutical therapies. Omega-3 fatty acids may help to prevent infection and complications in people undergoing surgical treatment for cancer, and may help relieve one of the most devastating manifestations of cancer, the fatigue and weight loss known as cachexia.
While additional studies are needed, the research findings to date suggest that omega-3 fatty acids may play an important role in both preventing cancer and augmenting the effectiveness of existing anti-cancer therapies.
1. Caygill CP, Charlett A, Hill MJ. Fat, fish, fish oil and cancer. Br J Cancer. 1996 Jul;74(1):159-64.
2. Jude S, Roger S, Martel E, et al. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol. 2006 Jan-Apr;90(1-3):299-325.
3. Kaizer L, Boyd NF, Kriukov V, Tritchler D. Fish consumption and breast cancer risk: an ecological study. Nutr Cancer. 1989;12(1):61-8.
4. Hardman WE. Omega-3 fatty acids to augment cancer therapy. J Nutr. 2002 Nov;132(11 Suppl):3508S-12S.
5. Calder PC. n-3 fatty acids, inflammation, and immunity—relevance to postsurgical and critically ill patients. Lipids. 2004 Dec;39(12):1147-61.
6. Hirose K, Takezaki T, Hamajima N, Miura S, Tajima K. Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. Int J Cancer. 2003 Nov 1;107(2):276-82.
7. Sakauchi F, Mori M, Washio M, et al. Dietary habits and risk of urothelial cancer incidence in the JACC Study. J Epidemiol. 2005 Jun;15 Suppl 2:S190-5.:S190-S195.
8. Wakai K, Tamakoshi K, Date C, et al. Dietary intakes of fat and fatty acids and risk of breast cancer: a prospective study in Japan. Cancer Sci. 2005 Sepb;96(9):590-9.
9. Roynette CE, Calder PC, Dupertuis YM, Pichard C. n-3 polyunsaturated fatty acids and colon cancer prevention. Clin Nutr. 2004 Apr;23(2):139-51.
10. Bartram HP, Gostner A, Reddy BS, et al. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio. Eur J Cancer Prev. 1995 Jun;4(3):231-7.
11. Aktas H, Halperin JA. Translational regulation of gene expression by omega-3 fatty acids. J Nutr. 2004 Sep;134(9):2487S-91S.
12. Davidson LA, Nguyen DV, Hokanson RM, et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 2004 Sep 15;64(18):6797-804.
13. Bartram HP, Gostner A, Scheppach W, et al. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology. 1993 Nov;105(5):1317-22.
14. Rao CV, Hirose Y, Indramie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 2001 Mar 1;61(5):1927-33.
15. Rao CV, Reddy BS. Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats. Carcinogenesis. 1993 Jul;14(7):1327-33.
16. Wu M, Harvey KA, Ruzmetov N, et al. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer. 2005 Nov 10;117(3):340-8.
17. Abou-el-Ela SH, Prasse KW, Farrell RL, Carroll RW, Wade AE, Bunce OR. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res. 1989 Mar 15;49(6):1434-40.
18. Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, Bagga D. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology. 2001 Aug;58(2):283-8.
19. Bagga D, Anders KH, Wang HJ, Glaspy JA. Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer. 2002;42(2):180-5.
20. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC. Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br J Cancer. 2003 Nov 3;89(9):1686-92.
21. Rose DP. Dietary fatty acids and prevention of hormone-responsive cancer. Proc Soc Exp Biol Med. 1997 Nova;216(2):224-33.
22. Rose DP. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr. 1997 Decb;66(6 Suppl):1513S-22S.
23. McCarty MF. A wholly nutritional ‘multifocal angiostatic therapy’ for control of disseminated cancer. Med Hypotheses. 2003 Jul;61(1):1-15.
24. Tsuji M, Murota SI, Mortia I, et al. Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot Essent Fatty Acids. 2003 May;68(5):337-42.
25. Rose DP, Connolly JM. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer. 2000;37(2):119-27.
26. De Caterina R, Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol. 2005 Jul;206(2):103-16.
27. Wallace JM. Nutritional and botanical modulation of the inflammatory cascade—eicosanoids, cyclooxygenases, and lipoxygenases—as an adjunct in cancer therapy. Integr Cancer Ther. 2002 Mar;1(1):7-37.
28. Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr. 2004 Dec;134(12 Suppl):3427S-30S.
29. Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control. 2004 May;15(4):367-86.
30. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999 Sep;83(3):217-44.
31. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst. 1998 Nov 4;90(21):1637-47.
32. Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration toward human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer. 2006 Mar 27;94(6):842-53.
33. Kelavkar UP, Hutzley J, Dhir R, Kim P, Allen KG, McHugh K. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia. 2006 Feb;8(2):112-24.
34. Hebert JR, Rosen A. Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. Cancer Detect Prev. 1996;20(3):234-44.
35. Barascu A, Besson P, Le Floch O, Nougnoux P, Jordan ML. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int J Biochem Cell Biol. 2006 Feb;38(2):196-208.
36. Yee LD, Young DC, Rosol TJ, Vanbuskirk AM, Clinton SK. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr. 2005 May;135(5):983-8.
37. Rhodes LE, O’Farrell S, Jackson MJ, Friedman PS. Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation. J Invest Dermatol. 1994 Aug;103(2):151-4.
38. Shahbakhti H, Watson RE, Azurdia RM, Ferreira CZ, Garmyn M, Rhodes LE. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo. Photochem Photobiol. 2004 Sep;80(2):231-5.
39. Rhodes LE, Shahbakhti H, Azurdia RM, et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis. 2003 May;24(5):919-25.
40. Maheo K, Vibet S, Steghens JP, et al. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med. 2005 Sep 15;39(6):742-51.
41. Menendez JA, Lupu R, Colomer R, et al. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev. 2005 Jun;14(3):263-70.
42. Philpott M, Ferguson LR. Immunonutrition and cancer. Mutat Res. 2004 Jul 13;551(1-2):29-42.
43. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992 Jul;112(1):56-67.
44. Farreras N, Artigas V, Cardona D, Rius X, Trias M, Gonzalez JA. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005 Feb;24(1):55-65.
45. Nilsen DW, Almdahl SM, Svensson B, Vaage J, Rasmussen K, Osterud B. Lipopolysaccharide induced monocyte thromboplastin synthesis and coagulation responses in patients undergoing coronary bypass surgery after preoperative supplementation with n-3 fatty acids. Thromb Haemost. 1993 Dec;70(6):900-2.
46. Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999 Dec;134(12):1309-16.
47. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery. 2002 Nov;132(5):805-14.
48. Bauer J, Capra S, Battistutta D, et al. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr. 2005 Dec;24(6):998-1004.
49. Burns CP, Halabi S, Clamon GH, et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer. 2004 Jul 15;101(2):370-8.
50. Burns CP, Halabi S, Clamon GH, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res. 1999 Dec;5(12):3942-7.
51. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003 Oct;52(10):1479-86.
52. Moses AW, Slater C, Preston T, Barber MD, Fearon GC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004 Mar 8;90(5):996-1002.
Continued on Brain Food